Health · 1 sources covering this

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this excerpt from “Pharma Monopoly.”

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies
“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this excerpt from “Pharma Monopoly.”
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/0b21c882561c1d8646be7cc1ad25f4f2d282b2f2"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies"></iframe>

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

How 1 sources are covering this

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

More from Health

Therapists are using AI to take notes. Is it a useful tool or a breach of trust?

Cheaper, Alternative Health Plans Are Having a Moment, but Critics Urge Caution

STAT+: An AI biotech CEO sets the record straight on AI drug development hype

Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it

Reader

Trust & legal

Across the network